Pharmacies nationwide face delays as health-care tech company reports cyberattack
A leading health-care technology company is experiencing a network outage due to a "cyber security issue," pausing prescription services at pharmacies nationwide.
Chernobyl’s mutant wolves developing resistance to cancer, study says
Wolves in Chernobyl’s radiation zone appear to have adapted to the highly radioactive environment and appear resiliant against cancer, a study says.
Alzheimer blood test could be game-changer for early detection
At one time, the thought of a blood test for Alzheimer's seemed impossible, one doctor told FOX Business. Today, its even closer to becoming a reality and is considered a game changer.
Clearblue launches first at-home menopause test: 'Personal knowledge'
The Clearblue Menopause Stage Indicator allows women to identify which stage of menopause they’re likely in through a first-of-its-kind at-home test.
Delta launches new health technologies for in-flight medical emergencies: ‘As safe as possible’
To help ensure the safety of passengers, Delta Air Lines is rolling out upgrades to its onboard medical tools and technology. The chief health officer shared details.
Rural North Carolina hospital 11th forced to shut down, change services this year
A North Carolina hospital has shut down and nearby residents are outraged. This is the eleventh rural hospital to close in 2023.
UnitedHealth says seniors are catching up on delayed surgeries
A growing number of seniors are seeking out surgeries, particularly related to knees and hips, that may have been pushed off during the COVID pandemic.
Death toll rises in fungal meningitis outbreak tied to procedures in Mexico
The Centers for Disease Control and Prevention (CDC) is investigating a multinational outbreak of fungal meningitis that has already killed four people.
Bayer plans to shift focus away from women’s health drug research
Bayer has announced plans to shift its efforts away from women’s health to focus on diseases, cardiovascular disease, neurology, oncology and immunology.
Moderna adding 2,000 new workers this year
Moderna will add to its workforce and its U.S. real estate footprint, the biotech company announced in a press release Friday. The employees will be added by the end of the year.
Scientists have reversed the aging process in mice: Are humans next?
Johns Hopkins' Dr. Marty Makary says it may sound like "pie in the sky," but the aging process may be reversible after new findings from Harvard scientists.
New research suggests simple ways to help ease burnout
Although the research regarding simple ways to ease burnout was conducted on healthcare workers, the study's authors say the lessons can be applied to any profession.
Narcan maker gets fast-tracked for over-the-counter nasal spray
FDA fast tracks opioid reversing nasal spray, Narcan, for over-the-counter approval, hoping to combat the fentanyl crisis with this life saving medication.
FDA takes tougher line on fast-tracked drugs
The Food and Drug Administration relies on preliminary data to make the decision, but asks companies to conduct follow-up studies to confirm that the drug works.
Researchers discover how to delay the decay of cells and tissue, restore function
Researchers have discovered a way to delay the decay of tissues and cells after death and even restore function to those cells. This is promising for organ transplant survivability.
UnitedHealth sees growing enrollment in 2Q thanks to Optum Health
UnitedHealth saw an 18% boost in revenue to about $45.1 billion in 2Q. A big reason for the strong quarter was Optum Health's performance. Optum's revenue per customer increased by 30%
Curevac sues BioNTech over COVID-19 vaccine's mRNA technology
CureVac is suing Pfizer's German partner BioNTech for alleged patent infringement related to the development of their mRNA vaccines against COVID-19.
Blackstone to invest up to $250 million in Autolus Therapeutics of U.K.
Blackstone Inc. is investing as much as $250 million in U.K. biotechnology company Autolus Therapeutics PLC to fund the final stages of development of a new therapy to treat a serious form of leukemia, the companies said.
Merck COVID-19 pill sparks calls for access for lower income countries
The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say.
Bill & Melinda Gates Foundation gives Dare Bioscience a boost
Shares of Daré Bioscience, Inc., surged 63% ahead of Wednesday's opening bell after the biotech company reported a nearly $49 million grant from The Bill & Melinda Gates Foundation.